— De La Salle University
— De La Salle University
Move forward together.
De La Salle University values the health and well-being of each member of the Lasallian community especially in these trying times. The DLSU vaccination program is a step to move forward together as we remain committed to providing quality Lasallian education.
The vaccination program is part of Lasallians A.C.T., the institutional campaign that highlights the University’s actions against the coronavirus threat.
To complement the government vaccination program, DLSU joined the ICTSI Foundation Inc. consortium through De La Salle Philippines which procured the Moderna vaccine through a tripartite agreement. DLSU is also in coordination with other consortiums (i.e. the Unilab Consortium in procuring the Covovax vaccine) in procuring vaccines for the community in the soonest possible time.
This form is intended to update your COVID-19 vaccination status to form part of your medical records.
Please prepare a photo of your Vaccination Certificate for uploading.
Please use your DLSU email address to access the links.
The DLSU vaccination program covers the following groups in the Lasallian community:
Group 1: Faculty and non-teaching staff
Group 2: ESPs, direct-hire, independent contractors, affiliates
Group 3: Students
Group 4: Dependents, members of the household
The vaccination program initiated by DLSAA is a separate vaccination program from the DLSU vaccination program. Inquiries regarding the DLSAA vaccination program can be coursed through info@dlsaa.com.
For the members of the community who are interested, they may pre-register through the links below:
Students - https://bit.ly/DLSUStudentsVaccine
Faculty and staff - https://bit.ly/DLSUEmployeesVaccine
Incoming students - https://bit.ly/DLSUNewStudentsVaccine
The registration for the vaccination program will be done in groups and in batches.
DLSU procured two vaccines: Covovax and Moderna. The University has not procured any other vaccine brands at the moment.
Covovax is a Novavax-developed vaccine which has an “overall efficacy rate of 90.4 percent and a 93.2 percent efficacy against variants of interest and concern.” It is a protein-based COVID-19 vaccine that provides 100 percent protection against moderate and severe disease, 93.2 percent efficacy against variants of interest and concern, 91 percent efficacy in high-risk populations such as the elderly and those with comorbidities, and a 90.4 percent efficacy overall in the latest Phase 3 clinical study conducted in the US. This vaccine will be given to those who are 18 years old or older in two doses given 3 weeks apart.
Moderna, on the other hand, is an mRNA COVID-19 vaccine with a 94.1 percent efficacy rate in protecting against COVID-19 starting 14 days after the first dose. The World Health Organization also notes that the new variants of SARS-CoV-2, including the B.1.1.7 and the 501Y.V2, do not alter the effectiveness of the Moderna mRNA vaccine. Learn more about the Moderna vaccine here.
The schedule of vaccination will depend on the delivery of the vaccine to the vaccination center and the availability of the administration/inoculation spots in the vaccination centers managed by the healthcare service provider (HSP). At present, DLSU has commenced discussion with AC Health as our HSP.
Once the schedule is confirmed, you will be informed through email regarding your schedule (date and time) and vaccination center (location). An app may be used to facilitate this process (e.g. AC Health uses the HealthNow app).
The following are the indicative costs for the two vaccines: Moderna and Covovax.
Moderna - Php 3,600 (Php 1,375 per dose; Php 425 per jab)
Covovax - Php 2,850 (Php 1,000 per dose; Php 425 per jab)
The indicative cost is subject to change and the final costs will be confirmed once finalized with our supplier/provider.
Yes, you have a choice. However, please consider that Moderna vaccines procured are only 5,600 doses and the bulk is targeted to arrive by late Q3 or Q4 2021. Covovax, on the other hand, is scheduled to arrive by the end of July or early August 2021 and we can further negotiate for the number of doses we may need since they are still open for orders (for the time being).
In compliance with DOLE Labor Advisory #3/s.2021, the University will subsidize the vaccine and administration costs for eligible employees under Groups 1 and 2.
For students, the process for paying as reimbursements for the vaccine and administration costs will be covered by a separate announcement before the schedule of the vaccination.
A separate announcement will be released about the payment process for student vaccinations.
You are required to update your pre-registration details using the following link:
Students - https://bit.ly/DLSUStudentsVaccine
Faculty and staff - https://bit.ly/DLSUEmployeesVaccine
Incoming students - https://bit.ly/DLSUNewStudentsVaccine
Click on the "EDIT YOUR RESPONSE" button to update your pre-registration details. This will allow us to update your details and provide the slot to others in the pre-registration list.
This will allow us to update your details and provide the slot to others in the pre-registration list.
However, to manage the number of vaccines we need (i.e. Covovax), we will be announcing cut-off schedules so we can assure availability of the vaccine. If you have already pre-registered before these cut-offs, you may not be allowed to cancel your registration as we consider this your commitment for the University to secure the vaccines.
DLSU will follow group prioritization based on the IATF guidelines, and rest assured that all pre-registered members of the community will be provided vaccines.
Vaccination is not the substitute for any health and safety protocol. At present, the default work arrangement is still work-from-home and classes are still online classes. However, the University continuously monitors IATF guidelines and adjusts our protocols accordingly.
As of now, there has been no formal recommendation from DOH, WHO and CDC about the timelines for the administration of booster shots. Hopefully, an update on this will be proposed in the coming months.
If you have concerns that are not covered by the FAQs, you may send an email to vaccination@dlsu.edu.ph (click the email address to automatically send an email). Please use an easily identifiable email subject so that our team can attend to your concerns immediately.
We follow FDA guidelines for granting the emergency use authorization (EUA) of the vaccines. Accordingly, Moderna can be given to 18 years old and above. Covovax, on the other hand, is still seeking EUA approval but based on the studies from Serum Institute of India (SII), they can be given to 18 years old and above as well.
All scholars are subsidized by the University. Non-scholars who may need financial assistance for the vaccination may apply to LSWP. The application process will be announced soon.
Yes. As long as you are able to register while you are a student, you will be included in the pre-registration list.
Ayala Corp Health has 24 vaccination centers nationwide. For the list of vaccination centers, please see here (slide 11 onwards). However, scheduling vaccination in these centers would depend on other factors including the number of vaccinees in the area and meeting the minimum order quantity.
At this point, you may still update your pre-registration to cancel your request for vaccines. We will announce the deadline for confirmation without cancellation once we are able to confirm the vaccine delivery.
We will announce the schedule once the pre-registration list is available after we get confirmation on the delivery schedule of our vaccines.
The roll-out schedule will be dependent on the arrival of the vaccines.
So far, DLSU has considered these two vaccines which have either confirmed delivery and have accepted pre-orders.
You may send an email to vaccination@dlsu.edu.ph and clinic@dlsu.edu.ph for medical and health-related concerns regarding the vaccines.
AC Health has 24 vaccination centers nationwide. For the list of vaccination centers, please see here (slide 11 onwards). However, scheduling vaccination in these centers would depend on other factors including the number of vaccinees in the area and meeting the minimum order quantity.